<unk>  affects approximately 2–8% of all<unk> gnancies worldwide. The incidence of<unk>  has risen in the U.S. since the 1990s, possibly as a result of increased<unk> valence of<unk> disposing disorders, such as chronic hypertension, diabetes, and obesity.<unk>  is one of the leading causes of maternal and<unk> rinatal morbidity and mortality worldwide. Nearly one-tenth of all maternal deaths in Africa and Asia and one-quarter in Latin America are associated with hypertensive diseases in<unk> gnancy, a category that encompasses<unk> .<unk>  is much more common in women who are<unk> gnant for the first time. Women who have<unk> viously been diagnosed with<unk>  are also more likely to experience<unk>  in subsequent<unk> gnancies.<unk>  is also more common in women who have<unk> -existing hypertension, obesity, diabetes, autoimmune diseases such as lupus, various inherited thrombophilias such as Factor V Leiden, renal disease, multiple gestation (twins or multiple birth), and advanced maternal age. Women who live at high altitude are also more likely to experience<unk> .<unk>  is also more common in some ethnic groups (e.g. African-Americans, Sub-Saharan Africans, Latin Americans, African Caribbeans, and Filipinos). Change of paternity in a subsequent<unk> gnancy has been implicated as affecting risk, except in those with a family history of hypertensive<unk> gnancy.<unk>  is a major complication of<unk> .<unk>  affects 0.56<unk> r 1,000<unk> gnant women in developed countries and almost 10 to 30 times as many women in low-income countries as in developed countries.
Pre-eclampsia
Eclampsia
Early pregnancy bleeding
Hypertensive disease of pregnancy
Gestational hypertension
Gestational diabetes
Antepartum bleeding
Recurrent miscarriage